Tag:
National Cancer Institute
Latest Headlines
Latest Headlines
Biomarker tool pilots cancer drugs into clinic
Patient stratification is one drug development area that stands to benefit from a biomarker solution developed for the National Cancer Institute. OncologyMAP aims also to help with drug re-tasking
Researchers get a jump on NCI trials group revamp
A rebel cell of cancer research organizations began doing the bidding of the National Cancer Institute even before NCI had articulated its clinical trial revamp plan. The American College of Surgeons
Interview: Steve Friedman on NCI's trial group overhaul
Steven Friedman, chief at the Operations and Informatics Branch for NCI's Cancer Therapy Evaluation Program, is leading the IT charge in the National Cancer Institute's overhaul of the Clinical
NCI trial-revamp plans call for IT overhaul
Imagine a comprehensive IT system, collecting standardized clinical trial data including volunteer information and outcomes. It's hardly a revolutionary idea, until you try to apply it across the
NCI seeks to build informatics resource
The National Cancer Institute is looking for information on evidence-based informatics. It wants to develop collaborations to create resources for clinicians. NCI is appealing to commercial IT,
The Hutch gains $17M to foster new cancer biomarker efforts
The National Cancer Institute is funneling $17 million to the renowned Fred Hutchinson Cancer Research Center in Seattle to pay for new discovery work on fresh cancer biomarkers along with
New cancer vax shows promise among late-stage victims
With support from the National Cancer Institute and Alphavax, researchers say that a new oncology vaccine has triggered a significant immune response among a group of patients suffering from a range
NCI plans clinical trial system reforms
Change is afoot at the National Cancer Institute, and clinical trials may never be the same again. NCI is becoming more data focused in drug development, according to new leadership, and is taking
Varmus to take helm at NCI
Harold Varmus, the renowned researcher credited with doubling the NIH budget during the Clinton administration, is coming back to take the reins of the National Cancer Institute and its $5 billion
NCI grant targets trial design improvement
A union of statistical and clinical experts is being put to a difficult task: improve the efficiency of the cancer clinical trial process. The multidisciplinary effort is being funded by a $12.5
